| News
Basel leads in international tax competition
20.12.2019
The canton of Basel-Stadt offers one of the world’s most attractive tax burdens for companies, according to the latest BAK Taxation Index. With an effective tax burden of 11 per cent, it has ranked seventh in the world for the first time.
Basel with Roche and Messe towers (img: Adriano Biondo)
The economic research institute BAK Economics has published the BAK Taxation Index 2019, which compares the tax burden on companies worldwide. The canton of Basel-Stadt has secured seventh place thanks to the significant tax cuts made within the corporate tax reform. Its effective tax rate is now 11 per cent (8.6 percentage points lower than previously).
The index shows that the Swiss cantons overall are still very well positioned in the international tax competition. According to BAK Economics, this is despite the fact that competition has significantly stepped up since the last index in 2017.
Alongside Basel-Stadt, Nidwalden, Lucerne, Appenzell Ausserrhoden and Obwalden are in the top seven. Hong Kong took the top spot. The international average for effective tax burden is 26.4 per cent, according to BAK. In Switzerland the value is more than 10 percentage points lower at 15.6 per cent.
Share this article
Sign up to receive our newsletter in your inbox.
You might also be interested in
docdok.health involved in coronavirus research project
A research project is investigating the improvement in the condition of patients who have been hospitalized due to COVID-19. docdok.health based in Basel is contributing the smartphone app for the project.
Read More
Celonic agrees cooperation to combat coronavirus
The Basel-based biopharmaceutical company Celonic Group has agreed a partnership with Airway Therapeutics from the USA. Together, the two companies are planning to develop a drug to treat coronavirus.
Read More
Idorsia receives payment of 45 million US dollars
The Allschwil-based pharmaceutical company Idorsia receives a payment of 45 million US dollars as part of an agreement with Neurocrine Biosciences and shall also be entitled to claim milestone payments in future. Neurocrine has exercised a licensing option for a drug developed by Idorsia to treat epilepsy..
Read More
Humard robot disinfects using UV light
Humard has developed a robot that can disinfect spaces using UV light. For this, the system manufacturer from the canton of Jura has adapted a mobile industrial robot that is otherwise used in warehouse logistics.
Read More
Roche authorized to distribute coronavirus antibody tests
Roche has received Emergency Use Authorization in the USA for an antibody test in connection with the novel coronavirus. The tests are already being distributed around the world. In May, production capacities are to already be scaled up to the high double-digit million area.
Read More
Basel is the most popular Swiss location for headquarters
Basel is valued as a location for company headquarters. In a rating from the fDi Intelligence platform of the Financial Times, Basel achieves eighth place in Europe. No other Swiss city does better.
Read More
